title: [Management of advanced prostate cancer in elderly patients].
abstract: With the increase of the senior demographic, an increase in cancer including prostate cancer has been seen. The challenge is to offer personalized cancer care because of population specificity. The only way is to share two experiences: the oncologist's experience who knows prostate cancer, prognosis and adverses effects of treatments and geriatrician's experience who consider old patients in their entirety thanks to comprehensive geriatric assessment (CGA). This article provides data about treatments of prostate cancer and geriatric evaluation to demonstrate the importance to work together for a "tailored" care.
authors.affiliation: ICO - centre René-Gauducheau, service d'oncologie médicale, boulevard Jacques-Monod, 44405 Nantes, France. emmanuelle.bompas@unicancer.fr
authors.forename: Emmanuelle
authors.initials: E
authors.lastname: Bompas
authors.forename: Laure
authors.initials: L
authors.lastname: Dedecker
mesh_terms: D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000517:prevention & control / Q000556:secondary; D019468:Disease Management; D015577:Geriatric Assessment / Q000379:methods; D006801:Humans; D008297:Male; D008495:Medical Oncology; D011471:Prostatic Neoplasms / Q000473:pathology / Q000628:therapy*
chemical_list: D000726:Androgen Antagonists; D000970:Antineoplastic Agents